Results 91 to 100 of about 4,536,092 (219)
Magnesium in primary hyperparathyroidism [PDF]
Serum magnesium concentration was determined pre- and post-operatively in 57 patients with primary hyperparathyroidism. No consistent abnormality of the serum magnesium level was found except for four cases who showed hypomagnesemia. It may be noteworthy
園田, 孝夫
core
The bone mineral density increments in patients with sporadic primary hyperparathyroidism after parathyroidectomy have been studied by several investigators, but few have investigated this topic in primary hyperparathyroidism associated with multiple ...
Flavia L. Coutinho +4 more
doaj +1 more source
Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review
ABSTRACT Background Chronic kidney disease (CKD) associated osteoporosis leads to an increased risk of bone fracture in patients with CKD. Evidence on the efficacy and safety of anti‐osteoporotic medications is limited for this group. This systematic review aimed to examine the efficacy and safety of anabolic parathyroid hormone (PTH) treatment in ...
Huriye Seyma Kafa +2 more
wiley +1 more source
Vitamin D: Physiology, Pharmacology and Clinical Evidence for Supplementation—A Narrative Review
ABSTRACT Vitamin D is a nutrient and prohormone obtained from diet and supplements and synthesized in the skin. It is essential for calcium and phosphate homeostasis and skeletal health and influences multiple extra‐skeletal processes, yet deficiency remains common worldwide.
Jyrki K. Virtanen
wiley +1 more source
Hypokalemic periodic paralysis: an unusual presentation of primary hyperparathyroidism
Primary hyperparathyroidism is an endocrine condition characterized by hyper secretion of parathyroid hormone (PTH). It has a wide varied clinical presentation from mild nonspecific symptoms to classical disease.
Rakesh Chandru K., Zahir Hussain S.
core +1 more source
ABSTRACT Extensive parenchymal brain calcification is uncommon in chronic kidney disease (CKD): intracranial vascular calcification affects up to 10% of uremic patients, but widespread Fahr‐type parenchymal deposits are rare and, where reported, have occurred in patients with a coexisting hypoparathyroid or parathyroid‐hormone (PTH)‐resistant state. We
Noorelle Khan, Nicholas Streicher
wiley +1 more source
Single and multiple gland disease in primary hyperparathyroidism [PDF]
The scope of this thesis is: To review diagnostic procedures in primary hyperparathyroidism To review localization studies of parathyroid glands in hyperparathyroidism primary To assess the optima!
Bonjer, H.J. (Jaap)
core +1 more source
In contrast to most developed countries, most patients with primary hyperparathyroidism in Brazil are still symptomatic at diagnosis. However, we have been observing a change in this pattern, especially in the last few years.
M.N. Ohe +9 more
doaj +1 more source
Graphical summary of the proposed mechanism displaying the synergistic effects of titanium dioxide nanoparticles (TNPs) exacerbating renal injury induced by CaP and UA crystals in HK2 cells. Store operated Ca2+ entry (SOCE) mediated Ca2+ influx promotes enhanced oxidative stress, activating inflammatory, fibrotic, and apoptotic pathways.
Samshritha R. Bikki +3 more
wiley +1 more source
Apoptosis in Primary Hyperparathyroidism
Primary hyperparathyroidism (PHPT) is defined by inappropriate elevation of parathormone, caused by parathyroid hyperplasia, also known as multi-gland disease (MGD), parathyroid adenoma (PA), or parathyroid carcinoma (PC). Although several studies have already been conducted, there is a lack of a definite diagnostic marker, which could unambiguously ...
Oliwia Segiet +7 more
openaire +3 more sources

